Sage Therapeutics Rocked on Kerrisdale Report, Cites ‘Enormous Downside’

Short seller front runners, Kerrisdale, is out with another report–crushing the souls and net worth of SAGE shareholders.

I love these reports. They’re all very dramatic and guided towards bountiful, almost guaranteed, profits for all parties involved who knew of this report’s existence before it was published.

Shares are barreling lower, with comical spirit!